Oramed Pharmaceuticals Receives Patent for Oral Delivery of Insulin

Oramed Pharmaceuticals Inc. (NASDAQCM:ORMP) received the patent from the European Patent Office, for its invention that allows the oral delivery of insulin.

As quoted in the press release:

…the European Patent Office has allowed the Company’s patent for its invention, titled “Methods and Compositions for Oral Administrations of Proteins.”

Click here to read the Oramed Pharmaceuticals Inc. (NASDAQCM:ORMP) press release